These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33930801)

  • 1. Overview of piperlongumine analogues and their therapeutic potential.
    Zhu P; Qian J; Xu Z; Meng C; Zhu W; Ran F; Zhang W; Zhang Y; Ling Y
    Eur J Med Chem; 2021 Aug; 220():113471. PubMed ID: 33930801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review.
    Piska K; Gunia-Krzyżak A; Koczurkiewicz P; Wójcik-Pszczoła K; Pękala E
    Eur J Med Chem; 2018 Aug; 156():13-20. PubMed ID: 30006159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer.
    Mitra S; Biswas P; Bandyopadhyay A; Gadekar VS; Gopalakrishnan AV; Kumar M; Radha ; Nandy S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2637-2650. PubMed ID: 37955690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Neolignans of the Genus Piper L.: Isolation Methods and Biological Activities.
    Macedo AL; Dos Santos TCC; Valverde AL; Moreira DL; Vasconcelos TRA
    Mini Rev Med Chem; 2017; 17(8):693-720. PubMed ID: 27903229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
    Han SS; Han S; Kamberos NL
    Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet activities of newly synthesized derivatives of piperlongumine.
    Park BS; Son DJ; Choi WS; Takeoka GR; Han SO; Kim TW; Lee SE
    Phytother Res; 2008 Sep; 22(9):1195-9. PubMed ID: 18697182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway.
    Thongsom S; Suginta W; Lee KJ; Choe H; Talabnin C
    Apoptosis; 2017 Nov; 22(11):1473-1484. PubMed ID: 28913568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperlongumine and its derivatives against cancer: A recent update and future prospective.
    Swain SS; Sahoo SK
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300768. PubMed ID: 38593312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide and its derivatives: Current achievements and future perspectives.
    Zhang H; Li S; Si Y; Xu H
    Eur J Med Chem; 2021 Nov; 224():113710. PubMed ID: 34315039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperlongumine, a constituent of Piper longum L., inhibits rabbit platelet aggregation as a thromboxane A(2) receptor antagonist.
    Iwashita M; Oka N; Ohkubo S; Saito M; Nakahata N
    Eur J Pharmacol; 2007 Sep; 570(1-3):38-42. PubMed ID: 17618620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of harmine and its derivatives: a review.
    Zhang L; Li D; Yu S
    Arch Pharm Res; 2020 Dec; 43(12):1259-1275. PubMed ID: 33206346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperlongumine as a potential activator of AMP-activated protein kinase in HepG2 cells.
    Ryu J; Kim MJ; Kim TO; Huh TL; Lee SE
    Nat Prod Res; 2014; 28(22):2040-3. PubMed ID: 24853732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells.
    Zhang Y; Ma H; Wu Y; Wu Z; Yao Z; Zhang W; Zhuang C; Miao Z
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2308-2312. PubMed ID: 28434764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diverse bioactivity of α-mangostin and its therapeutic implications.
    Chavan T; Muth A
    Future Med Chem; 2021 Oct; 13(19):1679-1694. PubMed ID: 34410182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
    Kumar S; Agnihotri N
    Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.
    Awasthee N; Shekher A; Rai V; Verma SS; Mishra S; Dhasmana A; Gupta SC
    Apoptosis; 2022 Apr; 27(3-4):261-282. PubMed ID: 35122181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibitory effect of piperlonguminine isolated from Piper longum on human cytochrome P450 1A2.
    Song M; Hwang JY; Lee MY; Jee JG; Lee YM; Bae JS; Kim JA; Lee SH; Lee S
    Arch Pharm Res; 2014 Aug; 37(8):1063-8. PubMed ID: 24194261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary metabolite profiling, cytotoxicity, anti-inflammatory potential and in vitro inhibitory activities of Nardostachys jatamansi on key enzymes linked to hyperglycemia, hypertension and cognitive disorders.
    Bose B; Tripathy D; Chatterjee A; Tandon P; Kumaria S
    Phytomedicine; 2019 Mar; 55():58-69. PubMed ID: 30668444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Pharmacological Evaluation of Novel Piperlongumine derivatives as Potential Antiplatelet Aggregation Candidate.
    Wang Y; Wang J; Li J; Zhang Y; Huang W; Zuo J; Liu H; Xie D; Zhu P
    Chem Biol Drug Des; 2016 Jun; 87(6):833-40. PubMed ID: 26706668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation.
    Liu X; Wang Y; Zhang X; Gao Z; Zhang S; Shi P; Zhang X; Song L; Hendrickson H; Zhou D; Zheng G
    Bioorg Med Chem; 2018 Aug; 26(14):3925-3938. PubMed ID: 29925484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.